Investor Presentaiton
Novo Nordisk Annual Report 2023
7 Property, plant and equipment
Financial statements of the parent company
Land and
Plant and
DKK million
Cost at the beginning of the year
Additions during the year
buildings
machinery
Other
equipment
Assets under
construction
2023
2022
23,801
25,384
4,489
12,018
65,692
55,995
822
219
150
21,229
22,420
10,223
Disposals during the year
(330)
(849)
(266)
(316)
(1,761)
(526)
Transfer from/(to) other items
597
800
509
(1,906)
Cost at the end of the year
24,890
25,554
4,882
31,025
86,351
65,692
Depreciation and impairment losses at the beginning of the year
11,328
16,918
2,899
31,145
28,988
Depreciation for the year
1,142
1,180
426
2,748
2,597
Impairment losses for the year
5
67
21
316
409
36
Depreciation reversed on disposals during the year
(326)
(855)
(276)
(316)
(1,773)
(476)
Depreciation and impairment losses at the end of the year
12,149
17,310
3,070
32,529
31,145
Carrying amount at the end of the year
12,741
8,244
1,812
31,025
53,822
34,547
Of which related to leased property, plant and equipment
1,011
72
1,083
580
Leased property, plant and equipment primarily relates to lease of office buildings, warehouses, laboratories and vehicles.
109View entire presentation